View Author
patient sarcoma cancer study imatinib treatment factor response survival tumor tissue group analysis disease therapy month trial doxorubicin trabectedin oncol grade tissue sarcoma phase prognostic lymphopenia chemotherapy ifosfamide metastatic european research stromal activity bone sarcoma group result j clin oncol mutation tumour stromal tumors cycle tissue sarcomas table journal model toxicity progression lymphocyte prognostic factors combination metastase retrospective analysis progression-free survival synovial count phase ii study kinase criteria synovial sarcoma translocation-related sarcomas imatinib mesylate antitumour activity level lymphoma verweij resistance agent hospital liposarcoma liver metastases regimen event oncology tumours non-gist group outcome performance status stromal tumours recist retrospective ifosfamide-based eortc
6 Most Recent Publications
|
A retrospective analysis of antitumour activity with trabectedin in translocation-related sarcomas
(Article)
Cesne, A. le Blay, J-Y. Grosso, F. Lardelli, P. Nieto, A. Alfaro, V. Verweij, J. Poveda, A. Casali, P.G. Demetri, G.D. Cresta, S. Maki, R.G. Balaña, C. Schöffski, P. |
2012-06-29
|
|
Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas. An exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG)
(Article)
Sleijfer, S. Ouali, M. Glabbeke, M.M.B. van Krarup-Hansen, A. Rodenhuis, S. Cesne, A. le Hogendoorn, P.C.W. Verweij, J. Blay, J-Y. |
2010-01-01
|
|
Gastrointestinal Stromal Tumors II: Medical Oncology and Tumor Response Assessment
(Article)
Benjamin, R.S. Debiec-Rychter, M. Cesne, A. le Sleijfer, S. Demetri, G.D. Joensuu, H. Schöffski, P. Poveda, A. |
2009-08-01
|
|
Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas
(Article)
Ray-Coquard, I. Cropet, C. Guastalla, J.P. Bachelot, T. Perol, D. Chabaud, S. Hogendoorn, P.C.W. Cassier, P. Dufresne, A. Blay, J-Y. Glabbeke, M.M.B. van Sebban, C. Cesne, A. le Judson, I.R. Tredan, O. Verweij, J. Biron, P. Labidi, I. |
2009-07-01
|
|
Imatinib does not induce cardiac left ventricular failure in gastrointestinal stromal tumours patients: Analyis of EORTC-ISG-AGITG study 62005
(Article)
Verweij, J. Casali, P.G. Kotasek, D. Cesne, A. le Reichard, P. Judson, I.R. Issels, R.D. Oosterom, A. van Glabbeke, M.M.B. van Blay, J-Y. |
2007-04-01
|
|
Brostallicin, an agent with potential activity in metastatic soft tissue sarcoma: A phase II study from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
(Article)
Leahy, M. Ray-Coquard, I. Judson, I.R. Blay, J-Y. Verweij, J. Cesne, A. le Duffaud, F. Hogendoorn, P.C.W. Fowst, C. Balincourt, C. de Paola, E.D. di Glabbeke, M.M.B. van |
2007-01-01
|
